【摘要】 目的 探讨胸水同型半胱氨酸、癌胚抗原724、β₂微球蛋白联合检测的临床价值。方法对44例恶性胸水患者及43例良性胸水患者的胸水进行同型半胱氨酸、癌胚抗原724、β₂微球蛋白联合检测分析。结果 恶性胸水患者胸水同型半胱氨酸、癌胚抗原724、β₂微球蛋白水平均显著高于良性胸水患者（P<0.01）;恶性胸水患者胸水同型半胱氨酸、癌胚抗原724、β₂微球蛋白单项检测阳性率分别为75.0%、84.09%、81.82%,3项联合检测阳性率（86.36%）高于单项检测结果。结论 胸水同型半胱氨酸、癌胚抗原724、β₂微球蛋白联合检测对鉴别恶性与良性胸水有较高的临床价值。更多还原

【Abstract】 Objective To investigate the clinical value of hydrothorax homocysteine,carcinoembryonic antigen 724（CEA 724） and β₂ microglobulin combined detection.Methods Combined detections and analyses of hydrothorax homocysteine,CEA 724 and β₂ microglobulin were conducted in 44 patients with malignant hydrothorax and 43 ones with benign hydrothorax.Results Hydrothorax homocysteine,CEA 724and β₂ microglobulin levels were significantly higher in patients with malignant hydrothorax than ones with benign（P<0.01）;single-item detection positive rate of homocysteine,CEA 724 and β₂ microglobulin were 75.0%,84.09%and 81.83%respectively in patients with malignant hydrothorax,3-item combined detection positive rate（83.36%） was higher than single-item.Conclusion Hydrothorax homocysteine,CEA 724 and β₂ microglobulin combined detection has higher clinical value for differentiating malignant from benign hydrothorax.更多还原